期刊文献+

IFN-γ对多发性骨髓瘤细胞上B细胞活化因子受体表达的影响及相关机制研究 被引量:1

IFN-γ up-regulated the expression of BAFF-R in multiple myeloma cells through the NF-κB pathway
原文传递
导出
摘要 目的 探讨IFN-γ对多发性骨髓瘤(multiple myeloma,MM)细胞上B细胞活化因子受体(BAFF-R)的表达变化影响及相关机制.方法 应用RT-PCR和ELISA法检测IFN-γ诱导多发性骨髓瘤细胞BAFF-R的表达水平,观察NF-κB特异性抑制剂BAY11-7082对其mRNA和蛋白表达水平的影响;应用Western blot检测NF-κB在IFN-γ诱导的多发性骨髓瘤细胞反应中的活化程度.结果 IFN-γ以时间和剂量依赖方式上调多发性骨髓瘤细胞BAFF-R表达.BAY11-7082以剂量依赖方式在基因转录和翻译水平显著抑制IFN-γ诱导的BAFF-R表达.结论 NF-κB信号通路参与了多发性骨髓瘤细胞BAFF-R的表达,如何参与有待进一步研究. Objective To investigate the action and mechanism of NF-κB pathway in up-regulating B cell-activating factor receptor (BAFF-R) expression in multiple myeloma cells induced by IFN-γ.Methods Activated NF-κB were detected with Western blot, while the expression of BAFF-R were measured with RT-PCR and ELISA, and investigated the effect of BAY11-7082 on transcription of BAFF-R mRNA and translation of protein in multiple myeloma cells stimulated by IFN-γ. Results IFN-γ can induce the degradation of IκB-α in time-dependent and dosage-dependent manner, and up-regulated BAFF-R expression in multiple myeloma cells. BAY11-7082, an NF-κB inhibitor, inhibited not only the transcription of BAFF-R mRNA but also the protein of regulated by IFN-γin dosage-dependent manner. Conclusion NFκB may play an important role in high expression of BAFF-R in multiple myeloma cells induced by IFN-γ.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2011年第1期20-24,共5页 Chinese Journal of Microbiology and Immunology
基金 江苏省医学重点建设学科资助(XK200723) 南通市社会发展科技计划($2007035) 江苏省六大人才高峰项目(2008095)
关键词 多发性骨髓瘤 BAFF-R受体 IFN-Γ NF-ΚB信号通路 Multiple myeloma BAFF receptor(BAFF-R) IFN-γ NF-κB pathway
  • 相关文献

参考文献22

  • 1Moore PA, Belvedere O, Orr A, et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science, 1999, 285 (5425) : 260-263.
  • 2Schneider P, MacKay F, Steiner V, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med, 1999, 189(11): 1747-1756.
  • 3Thompson JS, Bixler SA, Qian F, et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science, 2001, 293(5537) : 2108-2111.
  • 4Briones J, Timmerman JM, Hilbert DM, et al. BLyS and BLyS receptor expression in non-Hodgkin's lymphoma. Exp Hematol, 2002, 30(2) : 135-141.
  • 5Fu L, Lin-Lee YC, Pham LV, et al. Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. Blood, 2006, 107 ( 11 ) : 4540- 4548.
  • 6Ju S, Zhang D, Wang Y, et al. Correlation of the expression levels of BLyS and its receptors mRNA in patients with systemic lupus erythematosus. Clin Biochem, 2006, 39(12): 1131-1137.
  • 7Yuan H, Wang Y, Wu X, et al. Characterization of the 5'-flanking region and regulation of transcription of human BAFF-R gene. DNA Cell Biol, 2010, 29(3) : 133-139.
  • 8Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol, 2002, 2(10) : 725-734.
  • 9Xiao W, Hodge DR, Wang L, et al. NF-kappaB activates IL-6 expression through cooperation with c-Jun and IL6-AP1 site, but is independent of its IL6-NF kappaB regulatory site in autocrine human multiple myeloma cells. Cancer Biol Ther, 2004, 3 (10): 1007-1017.
  • 10Wada K, Maeda K, Tajima K, et al. Expression of BAFF-R and TACI in reactive lymphoid tissues and B-cell lymphomas. Histopathology, 2009, 54(2) : 221-232.

二级参考文献11

  • 1Moore PA, Belvedere O, Orr A, et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science, 1999, 285(5425): 260-263.
  • 2Schneider P, MacKay F, Steiner V, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med, 1999, 189(11): 1747-1756.
  • 3Novak A J, Bram R J, Kay NE, et al. Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. Blood, 2002, 100(8) : 2973-2979.
  • 4Ju S, Zhang D, Wang Y, et al. Correlation of the expression levels of BLyS and its receptors mRNA in patients with systemic lupus erythematosus. Clin Biochem, 2006, 39(12) : 1131-1137.
  • 5Scapini P, Nardelli B, Nadali G, et al. G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J Exp Med, 2003, 197(3) : 297-302.
  • 6Gras MP, Laabi Y, Linares-Cruz G, et al. BCMA: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes. Int Immunol, 1995, 7(7) : 1093-1106.
  • 7Adachi Y, Yoshio-Hoshino N, Nishimoto N. The blockade of IL-6 signaling in rational drug design. Curt Pharm Des, 2008, 14 (12) : 1217-1224.
  • 8Nardelli B, Belvedere O, Roschke V, et al. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood, 2001, 97 ( 1 ) : 198-204.
  • 9Cilloni D, Martinelli G, Messa F, et al. Nuclear factor-κB as a target for new drug development in myeloid malignancies. Haematologica, 2007, 92(9) : 1224-1229.
  • 10Colcombet J, Hirt H. Arabidopsis MAPKs: a complex signalling network involved in multiple biological processes. Biochem J, 2008, 413(2) : 217-226.

共引文献1

同被引文献9

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部